Indication

Pruritus in hemodialysis-dependent chronic kidney disease

Pruritus in hemodialysis-dependent chronic kidney disease, historically termed uremic pruritus or chronic kidney disease-associated pruritus, is a debilitating systemic symptom characterized by persistent or recurrent itching without an underlying primary dermatologic cause. Read more about Pruritus in hemodialysis-dependent chronic kidney disease

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Pruritus in hemodialysis-dependent chronic kidney disease therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Pruritus in hemodialysis-dependent chronic kidney disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pruritus in hemodialysis-dependent chronic kidney disease.

Pruritus in hemodialysis-dependent chronic kidney disease, historically termed uremic pruritus or chronic kidney disease-associated pruritus, is a debilitating systemic symptom characterized by persistent or recurrent itching without an underlying primary dermatologic cause.

It specifically affects patients with end-stage renal disease who require maintenance hemodialysis, presenting as localized or generalized, often bilaterally symmetrical discomfort that commonly disrupts sleep and reduces quality of life.

The underlying pathophysiology is multifactorial and involves uremic toxin retention, systemic microinflammation with pro-inflammatory cytokine signaling, cutaneous xerosis, peripheral neuropathy, and central nervous system dysregulation marked by an imbalance between mu- and kappa-opioid receptor pathways.

Personalize your experience

Follow Pruritus in hemodialysis-dependent chronic kidney disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it